Total Payments
$770,837
2024 Payments
$52,227
Companies
35
Transactions
1,204
Medicare Patients
6,825
Medicare Billing
$1.4M
Payment Breakdown by Category
Other$664,117 (86.2%)
Travel$57,533 (7.5%)
Consulting$24,727 (3.2%)
Food & Beverage$23,548 (3.1%)
Education$852.62 (0.1%)
Gifts$59.40 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $610,019 | 363 | 79.1% |
| Travel and Lodging | $57,533 | 181 | 7.5% |
| Compensation for serving as faculty or as a speaker for a medical education program | $39,098 | 23 | 5.1% |
| Consulting Fee | $24,727 | 15 | 3.2% |
| Food and Beverage | $23,548 | 578 | 3.1% |
| Honoraria | $11,425 | 6 | 1.5% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $3,575 | 2 | 0.5% |
| Education | $852.62 | 35 | 0.1% |
| Gift | $59.40 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $319,445 | 374 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $160,581 | 233 | $0 (2024) |
| Dexcom, Inc. | $58,870 | 74 | $0 (2024) |
| Lilly USA, LLC | $54,253 | 80 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $44,120 | 61 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $37,430 | 60 | $0 (2020) |
| Abbott Laboratories | $30,233 | 64 | $0 (2024) |
| Amgen Inc. | $25,447 | 72 | $0 (2022) |
| Bayer Healthcare Pharmaceuticals Inc. | $21,116 | 22 | $0 (2023) |
| Mannkind Corporation | $16,899 | 51 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $52,227 | 76 | Novo Nordisk Inc ($27,359) |
| 2023 | $70,345 | 89 | Novo Nordisk Inc ($25,704) |
| 2022 | $102,338 | 117 | Novo Nordisk Inc ($41,407) |
| 2021 | $77,212 | 89 | Novo Nordisk Inc ($48,453) |
| 2020 | $55,244 | 92 | Novo Nordisk Inc ($28,457) |
| 2019 | $120,362 | 216 | Novo Nordisk Inc ($61,301) |
| 2018 | $142,142 | 222 | Novo Nordisk Inc ($59,809) |
| 2017 | $150,967 | 303 | Lilly USA, LLC ($36,957) |
All Payment Transactions
1,204 individual payment records from CMS Open Payments — Page 1 of 49
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: Automated insulin delivery system | ||||||
| 12/29/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $24.20 | General |
| Category: Automated insulin delivery system | ||||||
| 12/26/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: Diabetes Care | ||||||
| 12/26/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: Diabetes Care | ||||||
| 12/12/2024 | Dexcom, Inc. | DEXCOM G7 GSS (161) (Medical Supply) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,532.00 | General |
| Category: Endocrinology | ||||||
| 11/27/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: Diabetes Care | ||||||
| 11/26/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $9.48 | General |
| Category: Diabetes Care | ||||||
| 11/20/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $750.00 | General |
| Category: Diabetes | ||||||
| 11/11/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Diabetes Care | ||||||
| 11/08/2024 | Dexcom, Inc. | DEXCOM G7 GSS (161) (Medical Supply) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,532.00 | General |
| Category: Endocrinology | ||||||
| 11/08/2024 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $938.00 | General |
| Category: Diabetes | ||||||
| 11/07/2024 | Dexcom, Inc. | DEXCOM G7 GSS (161) (Medical Supply) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $2,298.00 | General |
| Category: Endocrinology | ||||||
| 10/30/2024 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $938.00 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $750.00 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $750.00 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $750.00 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: Diabetes Care | ||||||
| 10/09/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $750.00 | General |
| Category: Diabetes | ||||||
| 10/04/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,650.00 | General |
| Category: Diabetes Care | ||||||
| 10/04/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Consulting Fee | Cash or cash equivalent | $300.00 | General |
| Category: Diabetes Care | ||||||
| 10/04/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Travel and Lodging | In-kind items and services | $87.77 | General |
| Category: Diabetes Care | ||||||
| 10/04/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Travel and Lodging | In-kind items and services | $9.02 | General |
| Category: Diabetes Care | ||||||
| 09/24/2024 | Dexcom, Inc. | DEXCOM G7 GSS (161) (Medical Supply) | Food and Beverage | In-kind items and services | $135.32 | General |
| Category: Endocrinology | ||||||
| 09/18/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $132.55 | General |
| Category: Diabetes Care | ||||||
| 09/16/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $9.07 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,757 | 25,234 | $1.5M | $446,832 |
| 2022 | 17 | 1,700 | 27,418 | $1.5M | $444,467 |
| 2021 | 16 | 1,709 | 9,860 | $1.0M | $307,357 |
| 2020 | 17 | 1,659 | 9,231 | $710,767 | $239,966 |
Total Patients
6,825
Total Services
71,743
Medicare Billing
$1.4M
Procedure Codes
66
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 97 | 9,182 | $456,150 | $165,980 | 36.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 716 | 1,178 | $415,834 | $112,312 | 27.0% |
| J3111 | Injection, romosozumab-aqqg, 1 mg | Office | 2023 | 12 | 13,234 | $397,020 | $104,806 | 26.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 70 | 81 | $39,771 | $11,675 | 29.4% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 185 | 417 | $40,032 | $11,279 | 28.2% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 241 | 241 | $57,867 | $10,361 | 17.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 89 | 102 | $25,398 | $6,549 | 25.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 34 | 34 | $20,298 | $6,118 | 30.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 41 | 46 | $15,754 | $4,653 | 29.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 115 | 407 | $28,083 | $4,533 | 16.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $12,231 | $3,491 | 28.5% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 37 | 37 | $7,363 | $1,978 | 26.9% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2023 | 38 | 190 | $5,040 | $1,206 | 23.9% |
| 77081 | Dxa bone density measurement of forearm, finger, hand, or foot | Office | 2023 | 29 | 29 | $2,900 | $1,025 | 35.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 11 | 11 | $2,662 | $693.99 | 26.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 15 | 18 | $486.00 | $171.36 | 35.3% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 93 | 8,701 | $435,050 | $147,110 | 33.8% |
| J3111 | Injection, romosozumab-aqqg, 1 mg | Office | 2022 | 12 | 15,960 | $397,190 | $119,648 | 30.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 711 | 1,214 | $428,542 | $118,793 | 27.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 84 | 104 | $51,064 | $15,716 | 30.8% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 179 | 435 | $41,760 | $12,070 | 28.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 79 | 87 | $21,663 | $5,878 | 27.1% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 195 | 195 | $25,511 | $5,484 | 21.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 29 | 29 | $17,313 | $4,705 | 27.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 114 | 361 | $24,909 | $4,163 | 16.7% |
About Dr. Daniel Berger, MD
Dr. Daniel Berger, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Santa Barbara, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1669407680.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Berger, MD has received a total of $770,837 in payments from pharmaceutical and medical device companies, with $52,227 received in 2024. These payments were reported across 1,204 transactions from 35 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($610,019).
As a Medicare-enrolled provider, Berger has provided services to 6,825 Medicare beneficiaries, totaling 71,743 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Santa Barbara, CA
- Active Since 07/11/2006
- Last Updated 10/17/2011
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1669407680
Products in Payments
- FARXIGA (Drug) $138,797
- Ozempic (Drug) $121,690
- RYBELSUS (Drug) $52,788
- Rybelsus (Drug) $49,477
- JARDIANCE (Drug) $48,820
- TRULICITY (Drug) $43,554
- Tresiba (Drug) $38,720
- INVOKANA (Drug) $37,457
- Victoza (Drug) $26,783
- Prolia (Biological) $21,779
- BYDUREON (Drug) $21,572
- Kerendia (Drug) $21,116
- DEXCOM G7 GSS (161) (Medical Supply) $19,823
- AFREZZA (Drug) $16,899
- FREESTYLE LIBRE 3 (Device) $15,941
- Dexcom G6 Transmitter (Medical Supply) $12,397
- Dexcom CGM (Device) $11,601
- DEXCOM G6 TRANSMITTER (Device) $10,031
- FreeStyle Libre Pro (Device) $8,127
- Xultophy 100/3.6 (Drug) $7,339
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Santa Barbara
Dr. Tricia Westhoff-Pankratz, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $121,885
Endocrinology, Diabetes & Metabolism $121,885
Ashley Thorsell, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $9,526
Endocrinology, Diabetes & Metabolism $9,526
Kateryna Markova, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $3,192
Endocrinology, Diabetes & Metabolism $3,192
Muhammad Haq, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $1,806
Endocrinology, Diabetes & Metabolism $1,806
Charles Donner, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $1,082
Endocrinology, Diabetes & Metabolism $1,082
Mark Wilson, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $1,040
Endocrinology, Diabetes & Metabolism $1,040